Skip to main content
DocGo Inc. (DCGO)
NASDAQ: DCGO · IEX Real-Time Price · USD
2.930
-0.020 (-0.68%)
At close: May 31, 2024, 4:00 PM
3.010
+0.080 (2.73%)
After-hours: May 31, 2024, 6:59 PM EDT

DocGo Revenue

DocGo had revenue of $703.37M in the twelve months ending March 31, 2024, with 61.46% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $192.09M with 69.98% year-over-year growth. In the year 2023, DocGo had annual revenue of $624.29M with 41.72% growth.

Revenue (ttm)
$703.37M
Revenue Growth
+61.46%
P/S Ratio
0.42
Revenue / Employee
$241,295
Employees
2,915
Market Cap
297.59M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023624.29M183.77M41.72%
Dec 31, 2022440.52M121.80M38.21%
Dec 31, 2021318.72M224.63M238.74%
Dec 31, 202094.09M45.79M94.81%
Dec 31, 201948.30M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Procaps Group 414.10M
Revance Therapeutics 236.65M
AxoGen 163.73M
Kamada 149.55M
Spok Holdings 140.75M
Genfit 42.42M
Mersana Therapeutics 38.30M
XOMA Corporation 5.81M
Revenue Rankings

DCGO News

More News